CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.41-0.14 (-2.52%)
At close: 4:00PM EDT
| Previous close | 5.55 |
| Open | 5.54 |
| Bid | 5.25 x 1800 |
| Ask | 6.20 x 4000 |
| Day's range | 5.38 - 5.55 |
| 52-week range | 5.31 - 10.05 |
| Volume | 330,917 |
| Avg. volume | 829,130 |
| Market cap | 351.71M |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.22 |
| Earnings date | 05 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.94 |
- Zacks
CytomX Therapeutics (CTMX) Expected to Beat Earnings Estimates: Should You Buy?
CytomX Therapeutics (CTMX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Here's Why CytomX Therapeutics (CTMX) is Poised for a Turnaround After Losing 15.8% in 4 Weeks
CytomX Therapeutics (CTMX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Simply Wall St.
It's Unlikely That The CEO Of CytomX Therapeutics, Inc. (NASDAQ:CTMX) Will See A Huge Pay Rise This Year
The underwhelming share price performance of CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) in the past three years would...
© 2021 Verizon Media. All rights reserved.
